Skip to main content
Premium Trial:

Request an Annual Quote

Bioneer Zika Detection Kit Eligible for WHO Procurement

NEW YORK (GenomeWeb) – South Korean molecular diagnostics firm Bioneer announced today that its three-in-one test kit for the detection of Zika, dengue, and chikungunya viruses has been deemed eligible for procurement by the World Health Organization.

The AccuPower ZIKV (DENV, CHIKV) Multiplex Real-Time RT-PCR kit is a qualitative nucleic acid assay that uses Bioneer's ExiStation Molecular Diagnostic System to rapidly test for the three mosquito-borne viruses simultaneously. It incorporates Bioneer's Dual-HotStart RT-PCR technologies, which include hotstart in both the PCR and reverse transcription steps, enhancing sensitivity and specificity. It has been approved in both Europe and South Korea.

According to Bioneer, the WHO assessed the kit under its Emergency Use Assessment and Listing Procedure, which provides organizations, procurement agencies, and member states performance assurance for Zika diagnostics in order to expedite their availability. The procedure was put in place following the declaration of a Public Health Emergency of International Concern based on microcephaly cases linked to Zika infection.
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more